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Objectives:
The objective is to present the no call rate using SNP based NIPT (Panorama test Natera) in a single private hospital and to compare it with the existing published data.
Methods:
We registered all the cases of NIPT performed in our institution since 2013, all the tests are performed after having had a ultrasonography to date the pregnancy and rule out the possibility of vanishing twin. The use of NiPT in our setting is usually after the combined first trimester screening in a contingent manner. The cost of the test is covered by the patient. In cases of no call at first draw we offer a redraw in all cases except if the laboratory say so. Results: We have performed 1662 Panorama tests during the study period. In 26 cases (1,5 %) we had a no call result at first draw. In these group a second redraw was taken and was successful in the 74% of the cases yielding a proportion of definitive no call of 0,4%. Those cases with no result were either very low fetal fraction (2 cases) with normal combined screening, impossibility of obtain a DNA pattern (1 cases) that finally was a tetrasomy 18p, one suspicion of mosaicism 45X/46XX (normal karyotipe) and a overlooked vanishing twin.
From the aneuploidy screening there was no case of either Trisomy 21, 18 or 13, however the tetrasomy 18 p might be considered in the spectrum of Trisomy 18. Conclusions: Our no call rate using a SNP based test, Panorama, is lower in comparison with the available evidence from the laboratory, their more recent publication quotes a no call rate of 2,8 %. In our setting after redraw we have a 0,4 % no call rate. These results may be related to the fact of performing an early scan to rule out twins and to date the pregnancy. On the other hand the BMI of our population is lower compared with other countries, that's probably one of the reasons of having a higher fetal fraction that allows to report a result.
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Performance of the 13-week gross-anatomy survey in a primary care centre in the Netherlands Objectives: To determine the percentage of fetal congenital abnormalities detected at the 13-week gross-anatomy survey performed in concomitance of the dating scan or the combined test (CT) in an ultrasound primary care centre. Methods: This is a retrospective cohort study performed in a large primary care centre in the Netherlands. Pregnancies were included in the study if an ultrasound scan was performed between 11 and 13+6 weeks of gestation and if the estimated date of delivery (EDD) was between 01-01-2012 and 01-01-2016. Pregnancies were excluded from the study if no information on the second trimester structural anomaly scan was available or if postnatal follow-up was missing. Results: 11330 pregnancies were included in the study. Of these, 6694 (59.1%) received a CT and 4636 (40.9%) were dating scans. Out of all 11330 pregnancies, 73 (0.6%) showed chromosomal and 103 (1.0%) structural abnormalities. 29% (N=30) of all structural abnormalities were already detected during the first trimester, including all cases of the following: anencephaly (N=4), encephalocele (N=1), exomphalos (N=9), megacystis (N=2), missing foot (N=1) and missing kidney (N=1). Detection rate for gastroschisis was 67% (N=2), while heart abnormalities were detected in the first trimester in only 14% of cases (N=3). Conclusions: In a primary care setting where a gross anatomy survey is performed in concomitance of the CT or dating scan, one third of structural anomalies can already be detected in the first trimester. These mostly involve very severe abnormalities, while less severe anomalies are still mostly detected in the second trimester. With further training, more time allocated to the ultrasound examination and the performance of a systemic anatomy survey the detection rate could further increase.
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Why do patients refuse invasive prenatal testing? P. Sadlecki, M. Walentowicz-Sadlecka, P. Walentowicz, M. Grabiec
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Objectives: The most commonly performed prenatal invasive diagnostic procedure is second trimester amniocentesis. In recent years, determination of personalised risk for fetal chromosomal anomalies emerged as an important component of prenatal genetic counselling. Women in whom fetal risk for chromosomal aberrations is elevated are offered further testing. The aim of this study was to identify factors that may influence the decision to refuse invasive prenatal testing aimed at determination of fetal karyotype in a group of patients at increased risk of Trisomy 21. Methods: The analysis included 177 patients with singleton pregnancy, whose personalised risk score for Trisomy 21 calculated on the basis of the combined test exceeded 1:300. The following factors were analysed as potential determinants of the decision to refuse amniocentesis: maternal age (≥35 years), gravidity, number of miscarriages in previous pregnancies, educational status, marital status, indications to prenatal testing, gestational age at the time of prenatal testing, personalised risk score for fetal chromosomal aberrations and NT value. Results: A statistically significant relationship was found between the decision to refuse amniocentesis and the number of previous miscarriages, maternal educational level, NT values and personalised risk score for fetal chromosomal aberrations. Women with personalised risk scores for Trisomy 21 greater than 1:100 opted out of invasive prenatal diagnosis significantly less often than the remaining participants. Conclusions: In conclusion, the key role of high quality and accuracy of non-invasive diagnostic tests conducted in the first trimester should be emphasised as personalised risk score for fetal chromosomal aberrations determined based on their results is pivotal for further management of pregnancy. Equally important is to provide the patients with an accurate and comprehensible information about potential benefits and risks of invasive testing.
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